Drug profile · INN
duloxetine
APO-DULOXETINE
duloxetine (APO-DULOXETINE) is a serotonin transporter inhibitor. Associated with Alphapharm Pty Ltd.
EMA: approved TGA: approved NMPA: clinical trials Nervous system (N06) N06AX21
Patents linked 1
Pipeline programs 6
News articles 0
Drug details — duloxetine
- Class
- Nervous system (N06)
- Route
- —
- Patents
- 1
- Programs
- 6
- Data quality
- 0.89
Quick answer
duloxetine (APO-DULOXETINE) is a serotonin transporter inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN duloxetine
Brand APO-DULOXETINE
Mechanism Serotonin transporter inhibitor
Therapeutic class Nervous system (N06)
ATC code N06AX21
Originator Alphapharm Pty Ltd
Mechanism of action
Serotonin transporter inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is duloxetine?
duloxetine (APO-DULOXETINE) is a serotonin transporter inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for duloxetine?
APO-DULOXETINE is a marketed brand name for duloxetine. Check FDA Drugs@FDA for the current US label holder and prescribing information.